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Proposed PCB Congener
Groupings for
Epidemiological Studies
Health effects related to polychlorinated
biphenyls (PCBs), which include 209 possi-
ble congeners exhibiting a variety of chlo-
rine substitution patterns (Fig. 1), are the
subject ofnumerous research investigations.
Individual members of this family evoke
diverse responses in experimental models
and in humans. Certain PCB congeners
mimic hormones and are neurotoxic (1-3).
Others produce a dioxinlike response,
which has been attributed to steric homolo-
gy with 2,3,7,8-tetrachlorodibenzodioxin
(TCDD) (4,5). Epidemiologic studies have
tended to report health effects expressed as
the total ofindividual PCB congener levels
or as the concentration relative to a com-
mericial PCB mixture (e.g., Aroclor 1248,
1254, or 1260). However, as congener-spe-
cific analyses of serum, adipose tissue, and
other media become routinely available, it
is highly desirable to organize risk analysis
along biologically plausible lines, thereby
avoiding misclassification of exposure and
strengthening the toxicologic associations.
One approach to interpreting PCBs in
environmental materials is to group the
dioxinlike PCB congeners together. With
this method, a single index is computed as
the sum of the congener concentrations
weighted by their toxic equivalents relative
to TCDD (4,6). However, analogous
schema for estrogenic, neurotoxic, and
cytochrome P450-inducing PCBs are not
available at this time.
As a means of evaluating hormonal
effects, Wolff and Toniolo (7) proposed a
classification system based on structural,
biological, and pharmacokinetic considera-
tions. They assigned PCB congeners to
three groups: estrogenic/neurotoxic, antie-
strogenic (dioxinlike), and enzyme-induc-
ing [phenobarbital (PB)-type cytochrome
P450]. The desirability ofdeveloping such
a system has been raised recently with
respect to a number of ongoing research
investigations that are attempting to relate
exposure to organochlorines, including
PCBs, with breast cancer risk (8). One of
these studies, in which we are co-investiga-
Figure 1. Polychlorinated biphenyls. Positions
2,3,4,5,6 and 2',3',4',5',6' are substituted with H- or
CU. Positions 2,2',6, and 6' bear ortho-substituents.
Table 1. Majora PCB peaks occurring in house dust or human samples
Humans and house dust Human only Dustonly
Chlorobiphenyl Chlorobiphenyl Chlorobiphenyl
substitution substitution substitution
BZ#C Ring Id Ring 2 BZ# Ring 1 Ring 2 BZ# Ring 1 Ring 2
Group 1 (potentially estrogenic)
Group 1A(weak phenobarbital inducers, estrogenic, not persistent)
44 25 23 31 25 4
49 25 24 70 25 34
52 25 25
Group 1B (weak phenobarbital inducers, persistent)
101 25 245 174 236 2345
187 2356? 245 177 2356? 234
201 2356? 2345
Group 2 (potentially antiestrogenic and immunotoxic, dioxinlike)
Group 2A: non-ortho and mono-ortho substituted (moderately persistent)
66 34 24 126 34 345
74 4 245 156 34 2345
77 34 34 167 345 245
105 34 234 169 345 345
118 34 245
Group 2B: di-ortho substituted (limited dioxin acitvity, persistent)
128 234 234
138 234 245
170 234 2345
Group 3 (phenobarbital, CYP1A and CYP2B inducers, biologically persistent)
99 245 24 183 2346 245
153 245 245
180 2345 245
196 2345 2346
203 23456 245
aEither2% or more byweightof65 congeners in dust and high percentage in humans, or demonstrated
activity in one ofthe three groupings and present at 1% or more of65 congeners in dust or commonly
detected in humans.
bFrom Vorhees(9).
CBZ# is congener number as designated by Ballschmitter and Zell(10).
dRing 1 structure signifies biological activityfor class 1 and 2.
tors, is determining levels of PCBs in
house dust as well as blood, providing an
opportunity to assess exposure using inter-
nal and external measurements. As a start-
ing point for discussion and initial classifi-
cation, we suggest one possible set ofPCB
functional groupings (see Table 1) based
on existing literature (1-8,11-13) and
structure-activity considerations.
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DDT/DDE and Infant Exposure
The article by L6pez-Carrillo et al. (1),
which discusses the public health implica-
tions of using DDT in Mexico, is a wel-
come contribution to the literature. DDT
is a public health concern not only in the
countries still using the chemical but also in
those countries that have restricted, phased
out, or banned use of the chemical.
Presently, it is difficult to conclude ifDDT
contributes to breast cancer incidence, and
the lack of complete confidence in our
understanding of the relationship between
this xenoestrogen and breast cancer should
not prevent us from finding alternatives to
DDT that have less public health impact.
L6pez-Carrillo et al. (1) base their concern
for DDT primarily on the possible increase
of breast cancer with exposure. Although
this endpoint is of concern, toxicological
endpoints that deserve equal attention per-
tain to infant exposure.
Teratology studies by Eriksson et al.
(2-4) have investigated neurological and
developmental endpoints in neonatal mice.
Although work is still required to elicit the
nature of low-dose DDT damage to the
central nervous system in neonates, the
results of their work suggest that 1) the
neonatal period ofbrain development may
be similar to other perinatal periods in
which the brain is susceptible to xenobiotic
compounds and 2) susceptibility to dam-
age by DDT and similar-acting com-
pounds may be greatest during the height
ofrapid brain growth and during the rapid
development of muscarinic acetylcholine
receptors in the cerebral cortex (2-5).
Although a direct comparison between
the 10-day-old mice used in these studies
and 10-day-old humans cannot be made,
the sequence of events of brain develop-
ment between humans and rodents is quite
similar (6,7) That is, nerve production,
myelin formation, receptor development,
etc., are events that occur in the same
order in rodents and humans (7). At day
10, mice are in their last stages of neuron
production for the hippocampus and cere-
bellum (8). Antimitotic drugs are much
more toxic if exposure occurs earlier in
development when more neurons are being
produced (9,10). However, the first 2
weeks of postnatal life in the rodent are a
period of rapid development of synaptic
connections, transmitter systems, and
myelination. During this stage of brain
development, exposure to teratogens leads
to disruption ofsome or all ofthese events,
resulting in permanent injury. For exam-
ple, metals such as lead, cadmium, and
organotin can injure the brain at this stage,
as can hypothyroidism (11). The applica-
bility of these teratology study results to
the human situation will continue to
become clearer as future findings delineate
effects at developmental time points when
mice are more sensitive and when the
development of rodent and human neu-
rosystems are similar.
It was with the consideration of this
previously described experimental work
that a breast milk study was initiated in the
state ofWashington to access a population
of concern consisting primarily of low-
income Hispanics. We conducted this
study to 1) determine actual levels ofDDT
and DDE in breast milk of mothers resid-
ing in the Yakima River basin; 2) assess the
relative impact offish consumption on the
total DDT/DDE body burden; and 3)
determine if total DDT and DDE levels
received by breast-feeding infants were ele-
vated to potentially deleterious levels. Fish
collected from the Yakima River between
1989 and 1991 had DDT and DDE levels
among the highest recorded in the United
States (12). We were concerned that moth-
ers who frequently consumed Yakima River
bottom-feeding fish could have breast milk
DDT and DDE concentrations sufficiently
high to expose their infants to potentially
deleterious levels of these compounds.
Among the 36 individuals sampled (12
individuals for each of three cohorts: fish
consumers, Mexico-born nonconsumers,
and U.S.-born nonconsumers); results indi-
cated that fish consumption did not signifi-
cantly increase DDT/ DDE breast milk
concentrations. However, as has been
reported elsewhere, subjects born in Mexico
had significantly elevated levels of DDT
and DDE (p < 0.01) in breast milk com-
pared to levels found in subjects born in the
United States (1,13,14).
For each cohort sampled, an infant
DDT intake level was determined using
the breast milk value that included two-
thirds ofthat particular cohort. For a 5-kg
infant consuming 1 kg breast milk daily,
infant DDT intake levels for the cohorts
were in the range of 0.7-3.5 x 10-3
mg/kg/day. These results do not include
two outliers from the Mexico-born non-
consumer cohort who had DDT/DDE lev-
els greater than two standard deviations
from the mean. Our infant exposure values
derived from the cohort data (excluding
outliers) were more than two orders of
magnitude below the administered dose
used by Eriksson et al. (2-4). The two
women (considered outliers) had DDT
breast milk levels that correspond to the
elevated levels observed in women living in
Mexico. These DDT breast milk levels
would expose breast-feeding infants each
day to levels that are less than two orders
of magnitude from the one-time adminis-
tered dose given to neonatal mice.
Although DDT may contribute to an
increase in breast cancer, exposure to DDT
may also produce neurological and devel-
opmental endpoints of significance that
require consideration. The study conduct-
ed in Washington State and data on breast
milk DDT levels obtained from women in
Mexico indicate that infants may be
exposed to potentially deleterious levels of
these compounds through breast milk.
With DDT in our environment, various
populations can still be exposed to suffi-
ciently elevated DDT levels in the United
States that warrant concern. Also, due to
the influx ofMexico-born women into the
United States, their U.S.-born infants may
be a population of concern. Future
research in this area should consider the
feasibility of detecting these neurological
and developmental outcomes in individu-
als that have been previously exposed as
infants, and not just for those living in
areas where DDT is still in use but also in
countries or areas where use has been
banned or severly restricted.
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